diazoline has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arano, T; Asaoka, Y; Enooku, K; Fujiwara, N; Koike, K; Kondo, M; Kondo, Y; Minami, T; Nakagawa, H; Nakagomi, R; Sato, M; Shiina, S; Tateishi, R; Uchino, K; Yoshida, H | 1 |
| Chen, CJ; Chen, CL; Chen, DS; Chen, PJ; Liu, CJ; Lu, SN; Sun, CA; Wang, LY; Yang, HI; Yang, WS; You, SL | 1 |
2 other study(ies) available for diazoline and Chronic Hepatitis C
| Article | Year |
|---|---|
Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients.
Topics: Adiponectin; Aged; Biomarkers; Carbolines; Cause of Death; Female; Follow-Up Studies; Forecasting; Hepatitis C, Chronic; Humans; Interleukin-6; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Prognosis; Risk Factors; Time Factors | 2015 |
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.
Topics: Adult; Carbolines; Carcinoma, Hepatocellular; Diabetes Mellitus; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypertension; Lipase; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Obesity; Risk Factors; Taiwan | 2008 |